Archive - News 2016

Ethics approval received for Head & Neck 5000 3 year follow up study
A favourable ethics opinion for the Head & Neck 5000 3 year follow up study (subject to R & D approvals)

was received on 04th August 2016.

 

Head & Neck 5000 extension request approved 4th August 2016

Our application to the National Institute for Health Research for a 12 month extension to our research programme has been approved. The studies revised end date is now June 2017.

 

Professor Andy Ness to give a talk at the National BAHNON Conference to be held in Bristol on the 2nd September 2016.

The talk will be titled "Head & Neck Cancer: Insights into aetiology and prognosis from a clinical cohort"

 

Professor Andy Ness invited to give talk at the Macmillan Cancer Support meeting "Developments in the Management of Head & Neck Cancer" 14th July 2016.

The talk was titled "Head & Neck 5000 update" and gave a overview of the Head & Neck 5000 project to date.

 

Professor Andy Ness gives seminar at the DKFZ German Cancer Research Centre
in Heidelberg 12th July 2016.

Professor Andy Ness visited DKFZ German Cancer Research Centre and gave a seminar entitled "Head & Neck Cancer: Insights into aetiology and prognosis from a clinical cohort" Heidelberg, Germany, 12th July 2016.
 

Rhona Beynon and Chris Penfold to present poster abstracts at the NCRI cancer conference 6th-9th November 2016.

Rhona Beynon's poster abstract title is "Smoking and alcohol consumption as predictors of outcome in head and neck cancer, results from the head and neck 5000 study".

 

Chris Penfold's poster abstract title is "Change in tobacco and alcohol consumption following a diagnosis of head and neck cancer, results from head and neck 5000 study"

 

Gemma Davis and Pemith Rubasinha Liyanage poster abstract wins first prize for best poster 27th - 28th April 2016.

Gemma Davis and Pemith Rubasinha Liyanage poster abstract entitled "A national audit adherence to Royal College of Pathologists guidelines for MDS reporting of Oral Squamous Cell Carcinoma" won first prize for best poster at the British Society of Oral and Maxillofacial Pathology annual scientific meeting in Edinburgh.